Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faten A Sayed

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neuron|March 9, 2018
TREM2 and Amyloid Beta: A Love-Hate RelationshipJoe Udeochu, Faten A Sayed, Li Gan
Glia|April 22, 2016
Targeting microglia for the treatment of Alzheimer's DiseasePaul D Wes, Faten A Sayed, Frédérique Bard, et al.
Scientific Reports|August 15, 2020
Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microgliaMaria A Telpoukhovskaia, Kai Liu, Faten A Sayed, et al.
Neurobiology of Disease|August 17, 2023
Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse modelsMelanie Das, Wenjie Mao, Yuliya Voskobiynyk, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2018
Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathyFaten A Sayed, Maria Telpoukhovskaia, Lay Kodama, et al.
Nature Neuroscience|December 25, 2019
Microglial microRNAs mediate sex-specific responses to tau pathologyLay Kodama, Elmer Guzman, Jon I Etchegaray, et al.
Glia|June 2, 2016
Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitorThomas Möller, Frédérique Bard, Anindya Bhattacharya, et al.
Science Translational Medicine|December 1, 2021
AD-linked R47H-<i>TREM2</i> mutation induces disease-enhancing microglial states via AKT hyperactivationFaten A Sayed, Lay Kodama, Li Fan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neuron|March 9, 2018
TREM2 and Amyloid Beta: A Love-Hate RelationshipJoe Udeochu, Faten A Sayed, Li Gan
Glia|April 22, 2016
Targeting microglia for the treatment of Alzheimer's DiseasePaul D Wes, Faten A Sayed, Frédérique Bard, et al.
Scientific Reports|August 15, 2020
Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microgliaMaria A Telpoukhovskaia, Kai Liu, Faten A Sayed, et al.
Neurobiology of Disease|August 17, 2023
Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse modelsMelanie Das, Wenjie Mao, Yuliya Voskobiynyk, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2018
Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathyFaten A Sayed, Maria Telpoukhovskaia, Lay Kodama, et al.
Nature Neuroscience|December 25, 2019
Microglial microRNAs mediate sex-specific responses to tau pathologyLay Kodama, Elmer Guzman, Jon I Etchegaray, et al.
Glia|June 2, 2016
Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitorThomas Möller, Frédérique Bard, Anindya Bhattacharya, et al.
Science Translational Medicine|December 1, 2021
AD-linked R47H-<i>TREM2</i> mutation induces disease-enhancing microglial states via AKT hyperactivationFaten A Sayed, Lay Kodama, Li Fan, et al.
Pageof 1